Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

13/01/2022 06:00

Jan 13 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2021        Nov 30, 2020     Feb 28, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               86.66               80.82           122.90    
                   (+7.2 pct)          (-18.4 pct)      (+7.3 pct)  
  Operating            6.97                8.12            10.70    
                   (-14.2 pct)         (-55.9 pct)      (+0.3 pct)  
  Recurring            8.67                7.93            12.70    
                   (+9.3 pct)          (-60.2 pct)      (+7.4 pct)  
  Net                  6.22                5.72             9.90    
                   (+8.7 pct)          (-62.9 pct)      (+7.0 pct)  
  EPS               76.14 yen           70.04 yen       121.22 yen  
  EPS Diluted       76.09 yen           69.97 yen                   
  Ann Div                               83.50 yen        84.00 yen  
  -Q2 div           42.00 yen           41.75 yen                   
  -Q4 div                               41.75 yen        42.00 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T